Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors

Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and Vasoactive Intestinal Peptide (VIP) are neuropeptides involved in a diverse array of physiological and pathological processes through activating the PACAP subfamily of class B1 G protein-coupled receptors (GPCRs): VIP receptor 1 (VPAC1R), VI...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jessica, Piper, Sarah J., Zhao, Peishen, Miller, Laurence J., Wootten, Denise, Sexton, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331257/
https://www.ncbi.nlm.nih.gov/pubmed/35897648
http://dx.doi.org/10.3390/ijms23158069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331257/
https://www.ncbi.nlm.nih.gov/pubmed/35897648
http://dx.doi.org/10.3390/ijms23158069

Ejemplares similares